Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy

Overview of attention for article published in Biologics: Targets & Therapy, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 287)
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

twitter: 1 X user
patent: 2 patents

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 70 Dimensions

Readers on

mendeley: 108 Mendeley

Summary X Patents Wikipedia Dimensions citations

So far, Dimensions has found 70 publications that cite this research output.

70

The most recent citing publications are shown below. View all 70 publications that cite this research output on Dimensions.

Antitumor Activity of a Pyrrolobenzodiazepine Antibody–Drug Conjugate Targeting LGR5 in Preclinical Models of Neuroblastoma

Article in Pharmaceutics (July 2024)

Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk Neuroblastoma

Article in Cancers (May 2024)

Bispecific GD2 x B7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma

Preprint in bioRxiv (May 2024)